[HTML][HTML] Current research trends of nanomedicines
Owing to the inherent shortcomings of traditional therapeutic drugs in terms of inadequate
therapeutic efficacy and toxicity in clinical treatment, nanomedicine designs have received …
therapeutic efficacy and toxicity in clinical treatment, nanomedicine designs have received …
[HTML][HTML] Current research trends of nanomedicines
Q Liu, J Zou, Z Chen, W He, W Wu - Acta Pharmaceutica Sinica. B, 2023 - ncbi.nlm.nih.gov
Owing to the inherent shortcomings of traditional therapeutic drugs in terms of inadequate
therapeutic efficacy and toxicity in clinical treatment, nanomedicine designs have received …
therapeutic efficacy and toxicity in clinical treatment, nanomedicine designs have received …
Current research trends of nanomedicines
Q Liu, J Zou, Z Chen, W He… - Acta pharmaceutica …, 2023 - pubmed.ncbi.nlm.nih.gov
Owing to the inherent shortcomings of traditional therapeutic drugs in terms of inadequate
therapeutic efficacy and toxicity in clinical treatment, nanomedicine designs have received …
therapeutic efficacy and toxicity in clinical treatment, nanomedicine designs have received …
[PDF][PDF] Current research trends of nanomedicines
Q Liu, J Zou, Z Chen, W He, W Wu - researchgate.net
Owing to the inherent shortcomings of traditional therapeutic drugs in terms of inadequate
therapeutic efficacy and toxicity in clinical treatment, nanomedicine designs have received …
therapeutic efficacy and toxicity in clinical treatment, nanomedicine designs have received …
Current research trends of nanomedicines.
Q Liu, J Zou, Z Chen, W He, W Wu - Acta Pharmaceutica Sinica. B, 2023 - europepmc.org
Owing to the inherent shortcomings of traditional therapeutic drugs in terms of inadequate
therapeutic efficacy and toxicity in clinical treatment, nanomedicine designs have received …
therapeutic efficacy and toxicity in clinical treatment, nanomedicine designs have received …